News

NEWS

LATEST NEWS

A Call for Improving the Quality of Cancer Care in Geriatric Patients

Geriatric Assessment Instruments Underutilized Among Community Oncologists, Hematologists

Over half of evaluable patients who received an infusion of tisagenlecleucel achieved response.

Promising, Early Results for Combined HDAC and mTOR Inhibition in Relapsed/Refractory Hodgkin Lymphoma

Modern Radiation Therapy Limits Radiation Doses to Organs at Risk in Hodgkin Lymphoma

man in intensive care

Prevalence, Recovery of Anemia in Hospitalized Patients With Critical Illness

Keytruda Approval Expands Classical Hodgkin Lymphoma Indication

Brentuximab Vedotin Plus Nivolumab as Chemotherapy-Free Strategy for Hodgkin Lymphoma in Older Patients

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery

UPCOMING MEETINGS

December 5 – 8, 2020
62ND ASH ANNUAL MEETING AND EXPOSITION
San Diego Convention Center, San Diego, CA

Click here to view the full calendar

DRUG NEWS FROM MPR

FDA: More Data on Remestemcel-L for Graft-vs-Host Disease Needed

FDA Requires Boxed Warning Update for Benzodiazepines

FDA Approves New Treatment Option for Multiple Myeloma

Priority Review Granted to Tazemetostat for Follicular Lymphoma Indication

Esperoct Now Available for Treatment of Hemophilia A

Bomedemstat Receives Fast Track Status for Essential Thrombocythemia

Avatrombopag Designated Orphan Drug for Chemo-Induced Thrombocytopenia

Adakveo Approved for Sickle Cell Disease

FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma

Reblozyl Approved for Anemia in Beta Thalassemia

Next post in General Hematology

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery